Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 29, 2018 - Issue sup3: Omalizumab treatment in patients with severe chronic spontaneus urticaria: considerations from real-life experiences
Submit an article Journal homepage
355
Views
4
CrossRef citations to date
0
Altmetric
Omalizumab treatment in patients with severe chronic spontaneous urticaria: consideration on efficacy from real-life experiences

Omalizumab therapy in a patient with cronic spontaneous urticaria, ulcerative colitis, hypereosinophilia and prurigo Besnier: a case report

T. GriecoDermatologic Clinic Sapienza University of Rome, Rome, Italy; Correspondence[email protected]
View further author information
,
C. ChelloDermatologic Clinic Sapienza University of Rome, Rome, Italy; View further author information
,
V. FainaDermatologic Clinic Sapienza University of Rome, Rome, Italy; View further author information
,
V. V. GomesUOC Anatomical Pathology, Belcolle Hospital, Viterbo, Italy; View further author information
,
L. AleiDermatologic Clinic Sapienza University of Rome, Rome, Italy; View further author information
,
A. SernicolaDermatologic Clinic Sapienza University of Rome, Rome, Italy; View further author information
,
V. PanasitiCampus Bio Medico, Dermatologic Clinic, Rome, ItalyView further author information
&
S. CalvieriDermatologic Clinic Sapienza University of Rome, Rome, Italy; View further author information
 show all
Pages 10-13 | Received 20 Feb 2018, Accepted 19 Sep 2018, Published online: 03 Jan 2019
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Abstract

The case of a woman who suffered from CSU and prurigo Besnier, with a history of chronic hyper-eosinophilia, ulcerative colitis and thyroiditis, unresponsive to anti-histamines and steroids is reported. The patient received omalizumab treatment, and obtained resolution of urticaria along with improvement of cutaneous symptoms of prurigo.

Acknowledgements

Medical writing assistance of this paper was provided by Laura Brogelli, on behalf of Content Ed Net; this assistance was funded by Novartis.

Disclosure statement

The authors report no conflict of interest.

Additional information

Funding

This supplement was funded by Novartis.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later
PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.